BIOMAT Database Logo BIOMAT Database Logo

Synthesis of 1,2,3,4-tetrahydro-beta-carboline derivatives as hepatoprotective agents. II. Alkyl 1,2,3,4-tetrahydro-beta-carboline-2-carbodithioates. 1987

Y Saiga, and I Iijima, and A Ishida, and T Miyagishima, and K Shigezane, and T Oh-ishi, and M Matsumoto, and Y Matsuoka

UI MeSH Term Description Entries
D002243 Carbolines A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles. Carboline,Pyrido(4,3-b)Indole,Beta-Carbolines,Pyrido(4,3-b)Indoles,Beta Carbolines
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver

Related Publications

Y Saiga, and I Iijima, and A Ishida, and T Miyagishima, and K Shigezane, and T Oh-ishi, and M Matsumoto, and Y Matsuoka
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydro-beta-carboline derivatives.
May 1995, Chemical & pharmaceutical bulletin,
Y Saiga, and I Iijima, and A Ishida, and T Miyagishima, and K Shigezane, and T Oh-ishi, and M Matsumoto, and Y Matsuoka
Identification and quantification of 1,2,3,4-tetrahydro-beta-carboline, 2-methyl-1,2,3,4-tetrahydro-beta-carboline, and 6-methoxy-1,2,3,4-tetrahydro-beta-carboline as in vivo constituents of rat brain and adrenal gland.
January 1981, Biochemical pharmacology,
Y Saiga, and I Iijima, and A Ishida, and T Miyagishima, and K Shigezane, and T Oh-ishi, and M Matsumoto, and Y Matsuoka
Synthesis and biological evaluation of novel 1,2,3,4-tetrahydro-β-carboline derivatives as potential antibacterial agents.
May 2024, Bioorganic & medicinal chemistry letters,
Y Saiga, and I Iijima, and A Ishida, and T Miyagishima, and K Shigezane, and T Oh-ishi, and M Matsumoto, and Y Matsuoka
Distribution of 1,2,3,4-tetrahydro-beta-carboline and 6-methoxy-1,2,3,4-tetrahydro-beta-carboline in mice.
May 1984, Acta pharmacologica et toxicologica,
Y Saiga, and I Iijima, and A Ishida, and T Miyagishima, and K Shigezane, and T Oh-ishi, and M Matsumoto, and Y Matsuoka
Spasmolytic agents. 2. 1,2,3,4-Tetrahydro-2-naphthylamine derivatives.
November 1982, Journal of medicinal chemistry,
Y Saiga, and I Iijima, and A Ishida, and T Miyagishima, and K Shigezane, and T Oh-ishi, and M Matsumoto, and Y Matsuoka
Quantitation of urinary 1,2,3,4-tetrahydro-beta-carboline and 1-methyl-1,2,3,4-tetrahydro-beta-carboline by high-performance liquid chromatography.
March 1994, Journal of pharmaceutical sciences,
Y Saiga, and I Iijima, and A Ishida, and T Miyagishima, and K Shigezane, and T Oh-ishi, and M Matsumoto, and Y Matsuoka
The preparation and evaluation of 1-substituted 1,2,3,4-tetrahydro- and 3,4-dihydro-beta-carboline derivatives as potential antitumor agents.
January 2005, Chemical & pharmaceutical bulletin,
Y Saiga, and I Iijima, and A Ishida, and T Miyagishima, and K Shigezane, and T Oh-ishi, and M Matsumoto, and Y Matsuoka
[Synthesis of 1,3-disubstituted-1,2,3,4-tetrahydro-beta-carboline derivatives, and studies on their stereoisomers (author's transl)].
March 1974, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Y Saiga, and I Iijima, and A Ishida, and T Miyagishima, and K Shigezane, and T Oh-ishi, and M Matsumoto, and Y Matsuoka
[The reduction of 1,2,3,4-tetrahydro-1-oxo-beta-carboline].
June 1968, Acta pharmaceutica Hungarica,
Y Saiga, and I Iijima, and A Ishida, and T Miyagishima, and K Shigezane, and T Oh-ishi, and M Matsumoto, and Y Matsuoka
4-Aryl-1-piperazinylalkyl derivatives of 1,2,3,4-tetrahydro-beta-carboline ring system. Synthesis and preliminary in vivo studies.
December 1996, Die Pharmazie,
Copied contents to your clipboard!